1033534228626b2fb34804e40b0fac96.jpg

Mimaki launches new Mimaki 3DGD-1800 large format 3D printer 3D Printer Hardware

by Technologies

Mimaki’s 3D printing business has been intertwined with Israeli technologies from the start. The Japanese company is a leader in large format 2D inkjet technology just like many of the firms involved in the evolution of companies like Objet, which later became Stratasys. After launching the only credible material jetting alternative for Stratasys full color 3D printing, now Mimaki Europe closed an OEM deal with another Israeli company, Massivit (whose founders originated from the Objet team), to launch the new Mimaki 3DGD-1800 large format, high-speed 3D printer.

f63abc1ae61c0af20e3ae71afe1d5e69.jpg

3D Hubs launches manufacturing fund for COVID-19 efforts 3D Printing Service Providers

by Business

3D Hubs, a Netherlands-based online manufacturing platform, has launched the COVID-19 Manufacturing Fund in an effort to support initiatives that are tackling the lack of much-needed medical supplies across the globe. The company says the fund will provide resources to these projects, enabling them to scale up the production of medical equipment, including protective masks and ventilator components.

b4026700cd99693e4d518e1bc435164b.jpg

Biogelx welcomes new CEO Alison Clayton Bioprinting

by Business

Scotland-based biomaterials firm Biogelx has announced the appointment of a new CEO, Alison Clayton. Clayton will take over the leading position from Mitch Scanlan, who recently retired. The company has also announced the appointment of Margaret Temple to its board of directors as well as the completion of a successful round of fundraising.

427489ab193ede46e62936027fdb6c7b.jpg

FDA defines ventilator supply mitigation strategies for healthcare providers AM Industry

by Business

A letter published by the US Food and Drug Administration (FDA) provides recommendations for health care providers and facilities, based on the recently issued guidance, regarding the use of devices with patients who develop respiratory compromise from COVID-19 or other respiratory disorders. These are important guidelines to follow in order to implement ventilator supply mitigation strategies in the US but can be useful for healthcare institutions, product suppliers and government institutions in other parts of the world affected by the COVID-19 outbreak.